Herzuma’s Biosimilar Herzuma Finds EC Approval

Biosimilars reduce individual patient’s out-of-pocket medical expenses and lower the financial burden on insurance payers and national health agencies, according to Celltrion CEO Woosung Kee. Read More

483sOnline.com Your Personal Pre-inspection Toolkit

Rest easy knowing you can identify exactly what FDA investigators are focusing on – before they show up! Read More

Corindus Receives FDA Clearance for CorPath GRX System

The system broadens the capabilities of the CorPath robotic technology platform. Read More

International Devices and Diagnostics Monitor

Stay ahead of the competition with this resource that brings you a global picture of the medical device regulations that affect your business. Read More
The Solutions Center